Premature and Early Menopause in Relation to Cardiovascular Disease

Izaäk Schipper; Yvonne V. Louwers

doi:10.1055/s-0040-1722318

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2020; 38(04/05): 270-276
DOI: 10.1055/s-0040-1722318

Review Article

Premature and Early Menopause in Relation to Cardiovascular Disease

Izaäk Schipper

¹Division of Reproductive Medicine and Endocrinology, Department of Obstetrics and Gynecology, Erasmus MC University Center, Rotterdam, The Netherlands

,

Yvonne V. Louwers

¹Division of Reproductive Medicine and Endocrinology, Department of Obstetrics and Gynecology, Erasmus MC University Center, Rotterdam, The Netherlands

› Author Affiliations

Abstract

Postmenopausal women have an increased risk for cardiovascular diseases. It has been postulated that the loss of ovarian function and subsequent deficiency of endogenous estrogens after menopause contributes to this elevated risk of cardiovascular disease in postmenopausal women. Compared with woman entering menopause at the mean age of 51 years, in women with early menopause or premature ovarian insufficiency the risk for cardiovascular disease is even greater. These women lack the cardioprotective effect of endogenous estrogens for many more years than do women entering natural menopause. The majority of data assessing the risk of cardiovascular disease in relation to age at menopause and specifically premature menopause are derived from large epidemiological cohort studies. In addition, observations in women undergoing bilateral oophorectomy at an early age provide convincing evidence regarding association between early menopause or POI and the development of cardiovascular events and mortality. Moreover, genetic variants associated with earlier age at menopause have also been found to increase the risk of cardiovascular events in women. It has been substantiated that hormone replacement therapy (HRT) decreases the risk for ischemic heart disease and eliminates the increased cardiovascular disease mortality. It is therefore crucial to start HRT as soon as possible, particularly in women with premature ovarian insufficiency.

Keywords

early menopause - premature ovarian insufficiency - cardiovascular disease - mortality - hormone replacement therapy

Full Text

References

References
1 Virani SS, Alonso A, Benjamin EJ. et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: a report from the American Heart Association. Circulation 2020; 141 (09) e139-e596
2 Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis 2015; 241 (01) 211-218
3 Gameiro CM, Romão F, Castelo-Branco C. Menopause and aging: changes in the immune system--a review. Maturitas 2010; 67 (04) 316-320
4 Daan NM, Jaspers L, Koster MP. et al. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Hum Reprod 2015; 30 (10) 2376-2386
5 Janse F, Tanahatoe SJ, Eijkemans MJ, Fauser BC. Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis. Hum Reprod Update 2012; 18 (04) 405-419
6 Bernini GP, Moretti A, Sgró M. et al. Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause 2001; 8 (01) 43-50
7 Laughlin GA, Goodell V, Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab 2010; 95 (02) 740-747
8 Ouyang P, Vaidya D, Dobs A. et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009; 204 (01) 255-261
9 Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360 (06) 606-614
10 Honigberg MC, Zekavat SM, Aragam K. et al. Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA 2019; (epub ahead of print)
11 Webber L, Davies M, Anderson R. et al; European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016; 31 (05) 926-937
12 Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton III LJ. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006; 7 (10) 821-828
13 Jacobsen BK, Nilssen S, Heuch I, Kvåle G. Does age at natural menopause affect mortality from ischemic heart disease?. J Clin Epidemiol 1997; 50 (04) 475-479
14 Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006; 13 (02) 265-279
15 Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999; 52 (04) 303-307
16 Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003; 157 (10) 923-929
17 Rivera CM, Grossardt BR, Rhodes DJ. et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009; 16 (01) 15-23
18 Gold EB, Bromberger J, Crawford S. et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001; 153 (09) 865-874
19 Hu FB, Grodstein F, Hennekens CH. et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999; 159 (10) 1061-1066
20 Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. Maturitas 2006; 53 (02) 226-233
21 Roeters van Lennep JE, Heida KY, Bots ML, Hoek A. Collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol 2016; 23 (02) 178-186
22 Tao XY, Zuo AZ, Wang JQ, Tao FB. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric 2016; 19 (01) 27-36
23 Zhu D, Chung HF, Dobson AJ. et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health 2019; 4 (11) e553-e564
24 Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and stroke mortality: cohort study with 3561 stroke deaths during 37-year follow-up. Stroke 2004; 35 (07) 1548-1551
25 Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke 2009; 40 (04) 1044-1049
26 Baba Y, Ishikawa S, Amagi Y, Kayaba K, Gotoh T, Kajii E. Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause 2010; 17 (03) 506-510
27 Muka T, Oliver-Williams C, Kunutsor S. et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol 2016; 1 (07) 767-776
28 Shen L, Song L, Liu B. et al. Effects of early age at natural menopause on coronary heart disease and stroke in Chinese women. Int J Cardiol 2017; 241: 6-11
29 Nerbrand C, Lidfeldt J, Nyberg P, Scherstén B, Samsioe G. Serum lipids and lipoproteins in relation to endogenous and exogenous female sex steroids and age. The Women's Health in the Lund Area (WHILA) study. Maturitas 2004; 48 (02) 161-169
30 Rijpkema AH, van der Sanden AA, Ruijs AH. Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas 1990; 12 (03) 259-285
31 Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990; 12 (04) 321-331
32 Fonseca MIH, de Almeida-Pititto B, Bensenor IM. et al; ELSA-Brasil Research Group. Changes in lipoprotein subfractions following menopause in the Longitudinal Study of Adult Health (ELSA-Brasil). Maturitas 2019; 130: 32-37
33 Knauff EA, Westerveld HE, Goverde AJ. et al. Lipid profile of women with premature ovarian failure. Menopause 2008; 15 (05) 919-923
34 Yoshida T, Takahashi K, Yamatani H, Takata K, Kurachi H. Impact of surgical menopause on lipid and bone metabolism. Climacteric 2011; 14 (04) 445-452
35 Teixeira N, Mourits MJ, Oosterwijk JC. et al. Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy. Fam Cancer 2019; 18 (01) 19-27
36 Daan NM, Muka T, Koster MP. et al. Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age. J Clin Endocrinol Metab 2016; 101 (09) 3306-3315
37 Gunning MN, Meun C, van Rijn BB. et al; CREW Consortium. The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: a case-control study. PLoS One 2020; 15 (03) e0229576
38 Kok HS, van Asselt KM, van der Schouw YT. et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 2006; 47 (10) 1976-1983
39 Scott NS. Understanding hormones, menopause, and heart failure: still a work in progress. J Am Coll Cardiol 2017; 69 (20) 2527-2529
40 Laven JSE, Visser JA, Uitterlinden AG, Vermeij WP, Hoeijmakers JHJ. Menopause: genome stability as new paradigm. Maturitas 2016; 92: 15-23
41 Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril 2016; 106 (07) 1588-1599
42 Morris DH, Jones ME, Schoemaker MJ, McFadden E, Ashworth A, Swerdlow AJ. Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study. Am J Epidemiol 2012; 175 (10) 998-1005
43 Perk J, De Backer G, Gohlke H. et al; European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med 2012; 19 (04) 403-488
44 van Noord PA, Dubas JS, Dorland M, Boersma H, te Velde E. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril 1997; 68 (01) 95-102
45 Webber L, Anderson RA, Davies M, Janse F, Vermeulen N. HRT for women with premature ovarian insufficiency: a comprehensive review. Hum Reprod Open 2017; 2017 (02) hox007
46 Christ JP, Gunning MN, Palla G. et al. Estrogen deprivation and cardiovascular disease risk in primary ovarian insufficiency. Fertil Steril 2018; 109 (04) 594-600.e1
47 Hipp HS, Charen KH, Spencer JB, Allen EG, Sherman SL. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). Menopause 2016; 23 (09) 993-999
48 Kalantaridou SN, Naka KK, Papanikolaou E. et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89 (08) 3907-3913
49 Sarrel PM, Lindsay D, Rosano GM, Poole-Wilson PA. Angina and normal coronary arteries in women: gynecologic findings. Am J Obstet Gynecol 1992; 167 (02) 467-471
50 Rocca WA, Gazzuola-Rocca L, Smith CY. et al. Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study. Mayo Clin Proc 2016; 91 (11) 1577-1589
51 Hayashi K, Mizunuma H, Fujita T. et al. Design of the Japan Nurses' Health Study: a prospective occupational cohort study of women's health in Japan. Ind Health 2007; 45 (05) 679-686
52 Lee C, Dobson AJ, Brown WJ. et al. Cohort profile: the Australian Longitudinal Study on Women's Health. Int J Epidemiol 2005; 34 (05) 987-991
53 Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 2006; 35 (01) 34-41
54 Seib C, Whiteside E, Humphreys J. et al. A longitudinal study of the impact of chronic psychological stress on health-related quality of life and clinical biomarkers: protocol for the Australian Healthy Aging of Women Study. BMC Public Health 2014; 14: 9
55 Sudlow C, Gallacher J, Allen N. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 2015; 12 (03) e1001779
56 Wadsworth M, Kuh D, Richards M, Hardy R. Cohort profile: the 1946 National Birth Cohort (MRC National Survey of Health and Development). Int J Epidemiol 2006; 35 (01) 49-54
57 Bain C, Willett W, Hennekens CH, Rosner B, Belanger C, Speizer FE. Use of postmenopausal hormones and risk of myocardial infarction. Circulation 1981; 64 (01) 42-46
58 Arnett DK, Blumenthal RS, Albert MA. et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140 (11) e596-e646
59 Grundy SM, Stone NJ, Bailey AL. et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73 (24) 3168-3209
60 He C, Kraft P, Chen C. et al. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet 2009; 41 (06) 724-728
61 He C, Murabito JM. Genome-wide association studies of age at menarche and age at natural menopause. Mol Cell Endocrinol 2014; 382 (01) 767-779
62 Stolk L, Perry JR, Chasman DI. et al; LifeLines Cohort Study. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet 2012; 44 (03) 260-268
63 Stolk L, Zhai G, van Meurs JB. et al. Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet 2009; 41 (06) 645-647
64 Day FR, Ruth KS, Thompson DJ. et al; PRACTICAL Consortium, kConFab Investigators, AOCS Investigators, Generation Scotland, EPIC-InterAct Consortium, LifeLines Cohort Study. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet 2015; 47 (11) 1294-1303
65 Sarnowski C, Kavousi M, Isaacs S. et al. Genetic variants associated with earlier age at menopause increase the risk of cardiovascular events in women. Menopause 2018; 25 (04) 451-457
66 Perry JR, Murray A, Day FR, Ong KK. Molecular insights into the aetiology of female reproductive ageing. Nat Rev Endocrinol 2015; 11 (12) 725-734
67 Dupuis J, Langenberg C, Prokopenko I. et al; DIAGRAM Consortium, GIANT Consortium, Global BPgen Consortium, Anders Hamsten on behalf of Procardis Consortium, MAGIC Investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42 (02) 105-116